PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31675671-10	2019	CONCLUSION: This study supports that novel pyridazinone derivates may be used for the development of new BChE inhibitory agents.	2-phenyl-3(2H)-pyridazinone	43-55	butyrylcholinesterase	Homo sapiens	105-109	
20712136-0	2010	Synthesis and antimicrobial, acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel ester and hydrazide derivatives of 3(2H)-pyridazinone.	2-phenyl-3(2H)-pyridazinone	142-160	butyrylcholinesterase	Homo sapiens	54-75	
25924828-2	2015	The newly designed ligands feature pyridazinone-based tricyclic scaffolds connected through alkyl chains of variable length to proper amine moieties (e.g., substituted piperazines or piperidines) for GPCR and cholinesterase (ChE) molecular recognition.	2-phenyl-3(2H)-pyridazinone	35-47	butyrylcholinesterase	Homo sapiens	209-223	
25924828-2	2015	The newly designed ligands feature pyridazinone-based tricyclic scaffolds connected through alkyl chains of variable length to proper amine moieties (e.g., substituted piperazines or piperidines) for GPCR and cholinesterase (ChE) molecular recognition.	2-phenyl-3(2H)-pyridazinone	35-47	butyrylcholinesterase	Homo sapiens	225-228